Treatment with new organic nitrites in pulmonary hypertension of acute experimental pulmonary embolism

Abstract Acute pulmonary embolism may cause right heart failure due to increased pulmonary vascular resistance and arterial hypoxemia. Effective vasodilator therapy of the pulmonary hypertension is highly needed. Therefore, we investigated the effects of a newly developed effective pulmonary vasodil...

Full description

Bibliographic Details
Main Authors: Kristofer F. Nilsson, Lars E. Gustafsson
Format: Article
Language:English
Published: Wiley 2019-02-01
Series:Pharmacology Research & Perspectives
Subjects:
Online Access:https://doi.org/10.1002/prp2.462
_version_ 1819044697231851520
author Kristofer F. Nilsson
Lars E. Gustafsson
author_facet Kristofer F. Nilsson
Lars E. Gustafsson
author_sort Kristofer F. Nilsson
collection DOAJ
description Abstract Acute pulmonary embolism may cause right heart failure due to increased pulmonary vascular resistance and arterial hypoxemia. Effective vasodilator therapy of the pulmonary hypertension is highly needed. Therefore, we investigated the effects of a newly developed effective pulmonary vasodilator, the organic mononitrites of 1,2‐propanediol (PDNO), in a rabbit model of acute pulmonary embolism. In anesthetized and ventilated rabbits, systemic and pulmonary hemodynamics, exhaled nitric oxide (NO), plasma nitrite concentration, and blood gases were monitored. First, dose–response experiments with intravenous and left heart ventricle infusions of PDNO and inorganic nitrite were done in naive animals and in pulmonary hypertension induced by a thromboxane A2 analogue. Second, acute pulmonary embolism was induced and either PDNO or placebo were administered intravenously within 20 minutes and evaluated within 1 hour after pulmonary embolization. PDNO intravenously, in contrast to inorganic nitrite intravenously, increased exhaled NO and counteracted pulmonary hypertension and vasodilated the systemic circulation, dose‐dependently, thereby showing efficient NO donation. Pulmonary embolization induced pulmonary hypertension and gas exchange disturbances. PDNO significantly decreased and normalized pulmonary vascular resistance and the right ventricle rate‐pressure product, without causing tolerance, with no significant side effects on the systemic circulation, nor on blood‐gas values or on methemoglobin formation. In conclusion, PDNO is a NO donor and an efficient vasodilator in the pulmonary circulation. Treatment with this or similar organic nitrites intravenously may be a future option to avoid right heart failure in life‐threatening acute pulmonary embolism.
first_indexed 2024-12-21T10:16:48Z
format Article
id doaj.art-166b742bb9564c9d8a975218094d3b8b
institution Directory Open Access Journal
issn 2052-1707
language English
last_indexed 2024-12-21T10:16:48Z
publishDate 2019-02-01
publisher Wiley
record_format Article
series Pharmacology Research & Perspectives
spelling doaj.art-166b742bb9564c9d8a975218094d3b8b2022-12-21T19:07:33ZengWileyPharmacology Research & Perspectives2052-17072019-02-0171n/an/a10.1002/prp2.462Treatment with new organic nitrites in pulmonary hypertension of acute experimental pulmonary embolismKristofer F. Nilsson0Lars E. Gustafsson1Department of Physiology and Pharmacology Karolinska Institute Stockholm SwedenDepartment of Physiology and Pharmacology Karolinska Institute Stockholm SwedenAbstract Acute pulmonary embolism may cause right heart failure due to increased pulmonary vascular resistance and arterial hypoxemia. Effective vasodilator therapy of the pulmonary hypertension is highly needed. Therefore, we investigated the effects of a newly developed effective pulmonary vasodilator, the organic mononitrites of 1,2‐propanediol (PDNO), in a rabbit model of acute pulmonary embolism. In anesthetized and ventilated rabbits, systemic and pulmonary hemodynamics, exhaled nitric oxide (NO), plasma nitrite concentration, and blood gases were monitored. First, dose–response experiments with intravenous and left heart ventricle infusions of PDNO and inorganic nitrite were done in naive animals and in pulmonary hypertension induced by a thromboxane A2 analogue. Second, acute pulmonary embolism was induced and either PDNO or placebo were administered intravenously within 20 minutes and evaluated within 1 hour after pulmonary embolization. PDNO intravenously, in contrast to inorganic nitrite intravenously, increased exhaled NO and counteracted pulmonary hypertension and vasodilated the systemic circulation, dose‐dependently, thereby showing efficient NO donation. Pulmonary embolization induced pulmonary hypertension and gas exchange disturbances. PDNO significantly decreased and normalized pulmonary vascular resistance and the right ventricle rate‐pressure product, without causing tolerance, with no significant side effects on the systemic circulation, nor on blood‐gas values or on methemoglobin formation. In conclusion, PDNO is a NO donor and an efficient vasodilator in the pulmonary circulation. Treatment with this or similar organic nitrites intravenously may be a future option to avoid right heart failure in life‐threatening acute pulmonary embolism.https://doi.org/10.1002/prp2.462alkyl nitriteschromatographyhigh pressure liquidhypertensioninorganic nitritelung
spellingShingle Kristofer F. Nilsson
Lars E. Gustafsson
Treatment with new organic nitrites in pulmonary hypertension of acute experimental pulmonary embolism
Pharmacology Research & Perspectives
alkyl nitrites
chromatography
high pressure liquid
hypertension
inorganic nitrite
lung
title Treatment with new organic nitrites in pulmonary hypertension of acute experimental pulmonary embolism
title_full Treatment with new organic nitrites in pulmonary hypertension of acute experimental pulmonary embolism
title_fullStr Treatment with new organic nitrites in pulmonary hypertension of acute experimental pulmonary embolism
title_full_unstemmed Treatment with new organic nitrites in pulmonary hypertension of acute experimental pulmonary embolism
title_short Treatment with new organic nitrites in pulmonary hypertension of acute experimental pulmonary embolism
title_sort treatment with new organic nitrites in pulmonary hypertension of acute experimental pulmonary embolism
topic alkyl nitrites
chromatography
high pressure liquid
hypertension
inorganic nitrite
lung
url https://doi.org/10.1002/prp2.462
work_keys_str_mv AT kristoferfnilsson treatmentwithneworganicnitritesinpulmonaryhypertensionofacuteexperimentalpulmonaryembolism
AT larsegustafsson treatmentwithneworganicnitritesinpulmonaryhypertensionofacuteexperimentalpulmonaryembolism